The higher prevalence of IL-2-producing SARS-CoV-2-specific cell clones could support the predominance of CD4+, rather than CD8+, T lymphocytes as expression of immune memory in patients who overcome COVID-19 [35]. This evidence concerns the gene CD8A and COVID-19.